January 14, 2014 | 1 pm ET
Accountable care organizations (ACOs) have the potential to lower costs and improve health care quality through incentives and coordinated care. However, the design brings with it many new challenges, including optimizing the value of pharmaceuticals. Many ACOs have not yet focused on this integral facet of care, even though medications are a critical component to achieving the lower costs and improved quality that are anticipated with this new model.
NPC hosted a webinar on January 14, 2014, to discuss research that explores how ready ACOs are to implement the structures and processes needed to maximize the value of pharmaceuticals. Speakers outlined the activities that ACOs are doing well, and shared insights on where there is room for improvement.
- Marv Feldman, RPh, MS, Managing Principal of Pharmacy Consulting and Senior Director of Medication Management, Premier Inc.
- Jerry Penso, MD, MBA, Chief Medical and Quality Officer, American Medical Group Association
- Kimberly Westrich, MA, Director, Health Services Research, National Pharmaceutical Council
- Moderator: Robert W. Dubois, MD, PhD, Chief Science Officer, National Pharmaceutical Council